| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 195.02B | 182.84B | 166.62B | 137.40B | 104.69B | 73.37B |
| Gross Profit | 19.08B | 18.70B | 12.68B | 10.10B | 5.78B | 6.29B |
| EBITDA | 10.80B | 11.07B | 14.97B | 10.08B | -7.12B | 1.59B |
| Net Income | 6.51B | 6.20B | 616.19M | -1.40B | -15.84B | -4.13B |
Balance Sheet | ||||||
| Total Assets | 118.91B | 117.87B | 112.90B | 106.70B | 76.80B | 54.72B |
| Cash, Cash Equivalents and Short-Term Investments | 31.17B | 43.14B | 33.07B | 35.43B | 28.91B | 10.88B |
| Total Debt | 23.68B | 23.17B | 27.25B | 23.88B | 15.28B | 34.69B |
| Total Liabilities | 59.82B | 54.90B | 57.53B | 53.49B | 36.41B | 57.62B |
| Stockholders Equity | 53.83B | 55.32B | 48.16B | 46.58B | 37.94B | -5.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 15.17B | 10.87B | 8.31B | 1.97B | 6.98B |
| Operating Cash Flow | 0.00 | 20.79B | 16.35B | 13.31B | 6.21B | 10.20B |
| Investing Cash Flow | 0.00 | -840.45M | -15.10B | -13.11B | -11.12B | -8.77B |
| Financing Cash Flow | 0.00 | -11.49B | -5.55B | 1.48B | 16.60B | -3.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$143.01B | 13.15 | 14.02% | 3.05% | 12.64% | 2.90% | |
73 Outperform | HK$94.22B | 9.94 | 7.51% | ― | 11.05% | 81.01% | |
64 Neutral | HK$46.81B | 11.39 | 9.46% | 6.39% | -17.69% | -3.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$12.00B | 5.27 | 8.00% | 3.55% | 26.36% | -18.67% | |
62 Neutral | HK$2.38B | 21.77 | 9.22% | 8.25% | 56.58% | 1963.38% | |
61 Neutral | HK$91.56B | 24.42 | 5.53% | ― | 12.14% | ― |